12 Health Care Stocks Moving In Thursday’s Pre-Market Session [Benzinga]
Thursday, February 29, 2024 1 min read
Key Takeaway: Enveric Biosciences experienced a significant stock increase of 162.3%, reaching a price of $2.18 during Thursday's pre-market session. The company's current market capitalization stands at $5.9 million. Despite this rise, Enveric remains a development stage company with no marketed products.
Price reaction · baseline $149.58 (2024-02-28 close) · hit pre-market · 2 other ENVB headline(s) in the window, move may be shared
day 0 close
+74.5%
day 1
+99.8%
day 3
+69.7%
Market Sentiment Analysis
POSITIVE FACTORS
Enveric Biosciences stock surged by 162.3%
Current stock price reached $2.18
Market cap increased to $5.9 million
Full Press Release Details
Enveric Biosciences stock rose 162.3% to $2.18 during Thursday’s pre-market session. The company’s market cap stands at $5.9 million.
Full Article >>
Company
Team
Psybrary™
Pipeline
Investors
Enveric Biosciences is a development stage company that markets no products at this time. The content of this site is not intended to be promotional or to suggest any product or use of a product that has been approved by any regulatory body.
• Company
• Team
• Psybrary™
• Pipeline
• Investors Investor Overview Press Releases Media Coverage Events + Presentations Stock Information SEC Filings Corporate Governance News Alerts
• Contact
• Investor Overview
• Press Releases
• Media Coverage
• Events + Presentations
• Stock Information
• SEC Filings
• Corporate Governance
• News Alerts
• twitter
• facebook
• linkedin
Frequently Asked Questions
What caused the rise in Enveric Biosciences stock?
Enveric Biosciences stock rose 162.3% during Thursday's pre-market session.
What is the current stock price of Enveric Biosciences?
The current stock price of Enveric Biosciences is $2.18.
What is the market cap of Enveric Biosciences?
Enveric Biosciences has a market cap of $5.9 million.
Is Enveric Biosciences currently marketing any products?
No, Enveric Biosciences is a development stage company with no marketed products.